Abstract: There is provided a 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative which is useful in the treatment of respiratory syncytial virus (RSV) infection and for the prevention of disease associated with RSV infection. (Formula (1)).

Abstract: There are provided 5,6-dihydro-4H-dithieno[3,2-b:2?,3?-d]azepine derivatives (as defined in the disclosure) which are useful in the treatment of RSV infection and for the prevention of disease associated with RSV infection.

Abstract: A radio frequency transmission arrangement comprises a ground plate having an aperture comprising a slot with an elongate cross-section and substantially parallel sides, and a first and second transmission line. The thickness of the ground plate is greater than a width of the slot. The first transmission line comprises a first elongate conductor on a first side of the ground plate and has an end terminated with a first termination stub. The second transmission line comprises a second elongate conductor on the opposite side of the ground plate and has an end terminated with a second termination stub. The first transmission line is arranged to cross the slot at a point adjacent to the first termination stub, and the second transmission line is arranged to cross the slot at a point adjacent to the second termination stub.

Abstract: There are provided 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivatives which are useful in the treatment of respiratory syncytial virus (RSV) infection and for the prevention of disease associated with RSV infection.

Abstract: This invention relates to compounds, as defined in the specification, useful in the treatment of mycoses, compositions containing them and their use in therapy.

Abstract: This invention relates to a compound, as defined in the specification, useful in the treatment of mycoses, compositions containing it and its use in therapy.

Abstract: There are provided inter alia compounds which are intended to treat or prevent respiratory syncytial virus infections and associated disease particularly infections caused by the A and B strains thereof.

Abstract: There is provided inter alia a compound of formula (I): wherein R1, J, Ar, L, X, R3 and R4 are as defined in the specification, for use in the treatment of inflammatory disorders.

Abstract: An access point of a wireless communication network forms beams by applying a weightset for a beamforming weights matrix to signal streams. The Equivalent Isotropic Radiated Power (EIRP) that is emitted from an array of antenna elements at the access point is controlled by calibrating the transmission phase and gain of a respective transmit chain for each antenna element, providing a polar radiation model for an antenna element of the array, and determining a weightset for the weighting matrix subject to a constraint that a maximum total EIRP for the beams in combination in any azimuth direction is maintained within a predetermined EIRP limit, based at least on a spatial separation of the antenna elements, the polar radiation model and the calibrated transmission phase and gain of each respective transmit chain.

Abstract: There is provided a 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative which is useful in the treatment of respiratory syncytial virus (RSV) infection and for the prevention of disease associated with RSV infection. (Formula (1)).

Abstract: This invention relates to compounds, as defined in the specification and as represented by the compound of formula (I): that are useful in the treatment of mycoses, compositions containing them and their use in therapy.

Abstract: This invention relates to a compound, as defined in the specification and as represented by the compound of formula (I): useful in the treatment of mycoses, to compositions containing it and its use in therapy.

Abstract: This invention relates to compounds, as defined in the specification, useful in the treatment of mycoses, to compositions containing them and to their use in therapy.

Abstract: There is provided a 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative which is useful in the treatment of respiratory syncytial virus (RSV) infection and for the prevention of disease associated with RSV infection. (Formula (1)).

Abstract: An access point of a wireless communication network forms beams by applying a weightset for a beamforming weights matrix to signal streams. The Equivalent Isotropic Radiated Power (EIRP) that is emitted from an array of antenna elements at the access point is controlled by calibrating the transmission phase and gain of a respective transmit chain for each antenna element, providing a polar radiation model for an antenna element of the array, and determining a weightset for the weighting matrix subject to a constraint that a maximum total EIRP for the beams in combination in any azimuth direction is maintained within a predetermined EIRP limit, based at least on a spatial separation of the antenna elements, the polar radiation model and the calibrated transmission phase and gain of each respective transmit chain.

Abstract: There is provided a 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative which is useful in the treatment of respiratory syncytial virus (RSV) infection and for the prevention of disease associated with RSV infection. (Formula (1)).

Abstract: An access point (1) for use in a point to multipoint wireless network comprises a sector antenna (8) and an antenna array of antenna elements (7), the antenna elements not including the sector antenna, and the antenna elements being arranged to receive signals from the same sector as the sector antenna. A first beamformer (10) is configurable to form a first beam (11) from signals received at the antenna array and a selector switch (5) is switchable to at least a first state in which signals received at the sector antenna (8) are connected to a first receiver (2), and a second state in which signals received from the first beamformer (10) are connected to the first receiver (2). A scheduler is configured to set the selector switch (5) to the first state for at least a first receive timeslot and to the second state for at least a second receive timeslot.

Abstract: This invention relates to compounds, as defined in the specification and as represented by the compound of formula (I): that are useful in the treatment of mycoses, to compositions containing them and to their use in therapy.

Abstract: A radio frequency transmission arrangement comprises a ground plate having an aperture comprising a slot with an elongate cross-section and substantially parallel sides, and a first and second transmission line. The thickness of the ground plate is greater than a width of the slot. The first transmission line comprises a first elongate conductor on a first side of the ground plate and has an end terminated with a first termination stub. The second transmission line comprises a second elongate conductor on the opposite side of the ground plate and has an end terminated with a second termination stub. The first transmission line is arranged to cross the slot at a point adjacent to the first termination stub, and the second transmission line is arranged to cross the slot at a point adjacent to the second termination stub.

Abstract: There is provided a 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative which is useful in the treatment of respiratory syncytial virus (RSV) infection and for the prevention of disease associated with RSV infection. (Formula (1)).